Who is sponsoring NCT06101225?

NCT06101225 is sponsored by Universidade Autónoma de Lisboa.

What drugs are being tested in NCT06101225?

Interventions in NCT06101225: MindRegulation Intervention, Relaxation, Waiting List Control Group.

What condition does NCT06101225 study?

NCT06101225 studies Mental Health Wellness 1, Positive and Negative Affect, Social Skills, Happiness, Self Esteem, Self-Regulation, Emotion, Anxiety, Cognitive Change, Heart Rate Variability, Stress, Psychological, Physical Activity.

Is NCT06101225 still recruiting?

NCT06101225 is currently recruiting now. Last updated 7 November 2023.

Last reviewed 2023-11-07 · How we verify

NCT06101225: MR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Relaxation and Guided Imagery Intervention in School Context

Recruiting now NA Last updated 7 November 2023

What this trial tests

NA trial testing MindRegulation Intervention in Mental Health Wellness 1 in 240 participants. Currently enrolling.

Timeline

9 October 2023

Primary endpoint
30 July 2025

30 June 2026

Quick facts

Lead sponsor	Universidade Autónoma de Lisboa
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	240
Start date	9 October 2023
Primary completion	30 July 2025
Estimated completion	30 June 2026
Sites	1 location across Portugal

Drugs / interventions tested

MindRegulation Intervention
Relaxation
Waiting List Control Group

Conditions studied

Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →
Positive and Negative Affect — all drugs for Positive and Negative Affect →
Social Skills — all drugs for Social Skills →
Happiness — all drugs for Happiness →

Sponsor

Universidade Autónoma de Lisboa

Who can join

Adults 7 to 12, any sex, with Mental Health Wellness 1 or Positive and Negative Affect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Specific aims - To test the effects of a relaxation and guided imagery intervention with socioemotional learning content on a range of socioemotional, physiological, cognitive and academic outcomes of school-aged children, measured through self-reports, neuropsychological and physiological measures, as well as teachers and parent's reports.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

MindRegulation-SEL: randomized controlled trial of the effects of a relaxation and guided imagery intervention with socioemotional learning on the psychological and biophysiological well-being, socioemotional development, cognitive function and academic achievement of elementary
Galinha IC, de Carvalho JLDCS, de Oliveira ACP, Arriaga P, et al · · 2025 · PMID 40462190 · DOI 10.1186/s13063-025-08899-3
MindRegulation: Randomized Controlled Trial of the Effects of a Relaxation and Guided Imagery Intervention on the psychophysiological well-being, socioemotional regulation, cognitive and academic development of children in school
Galinha IC, Carvalho JS, Oliveira AC, Arriaga P, et al · · 2024 · DOI 10.21203/rs.3.rs-3906571/v1

Verify or expand the search:

Other recruiting trials for Mental Health Wellness 1

Currently open trials in the same condition.

NCT07128095 — COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise · recruiting
NCT06254924 — Qoyangnuptu: Qoyangnuptu Intervention (QI) App · NA · recruiting
NCT06254872 — Qoyangnuptu: Peer Mentor · NA · recruiting
NCT05865782 — Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes · NA · recruiting
NCT05825040 — Randomized Controlled Trial on Precision Mental Health · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06101225 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Autónoma de Lisboa
Last refreshed: 7 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06101225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing